Elias Maccioni

Dr. Elias Maccioni

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2016 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
RMRita Meleddu
Rita Meleddu
SDSimona Distinto
Simona Distinto
Angela CoronaAngela Corona
Angela Corona
Enzo TramontanoEnzo Tramontano
Enzo Tramontano
GBGiulia Bianco
Giulia Bianco
EMElias Maccioni
Elias Maccioni
A series of 3-3-{2-[2-3-methyl-4-phenyl-2,3-dihydro-1,3-thiazol-2-ylidene]hydrazin-1-ylidene-2,3-dihydro-1H-indol-2-one derivatives has been designed and synthesized to study their activity on both HIV-1 (Human Immunodeficiency Virus type 1) RT (Reverse Transcriptase) associated functions. These derivatives are analogs of previously reported series whose biological activity and mode of action have been investigated. In this work we investigated the influence of the introduction of a methyl group in the position 3 of the dihydrothiazole ring and of a chlorine atom in the position 5 of the isatin nucleus. The new synthesized compounds are active towards both DNA polymerase and ribonuclease H in the µM range. The nature of the aromatic group in the position 4 of the thiazole was relevant in determining the biological activity.

1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RMRita Meleddu
Rita Meleddu
SDSimona Distinto
Simona Distinto
Angela CoronaAngela Corona
Angela Corona
GBGiulia Bianco
Giulia Bianco
VCValeria Cannas
Valeria Cannas
EMElias Maccioni
Elias Maccioni

1 September 2002 in Il Farmaco
Verified
Journal Article
Closed access
EMElias Maccioni
Elias Maccioni
MCM.C Cardia
M.C Cardia
LBL Bonsignore
L Bonsignore
APA Plumitallo
A Plumitallo
MPM.L Pellerano
M.L Pellerano
ALA De Logu
A De Logu

1 November 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FEFrancesca Esposito
Francesca Esposito
FAFrancesca Alessandra Ambrosio
Francesca Alessandra Ambrosio
RMRita Maleddu
Rita Maleddu
Giosuè CostaGiosuè Costa
Giosuè Costa
Roberta RoccaRoberta Rocca
Roberta Rocca
Enzo TramontanoEnzo Tramontano
Enzo Tramontano

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
BFBenedetta Fois
Benedetta Fois
SDSimona Distinto
Simona Distinto
RMRita Meleddu
Rita Meleddu
SDSerenella Deplano
Serenella Deplano
EMElias Maccioni
Elias Maccioni
FCFilippo Cottiglia
Filippo Cottiglia
In an in vitro screening for human carbonic anhydrase (hCA) inhibiting agents from higher plants, the petroleum ether and ethyl acetate extracts of Magydaris pastinacea seeds selectively inhibited hCA IX and hCA XII isoforms. The phytochemical investigation of the extracts led to the isolation of ten linear furocoumarins (1–10), four simple coumarins (12–15) and a new angular dihydrofurocoumarin (11). The structures of the isolated compounds were elucidated based on 1 D and 2 D NMR, MS, and ECD data analysis. All isolated compounds were inactive towards the ubiquitous cytosolic isoform hCA I and II (Ki > 10,000 nM) while they were significantly active against the tumour-associated isoforms hCA IX and XII. Umbelliprenin was the most potent coumarin inhibiting hCA XII isoform with a Ki of 5.7 nM. The cytotoxicity of the most interesting compounds on HeLa cancer cells was also investigated.

21 May 2014 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
RMRita Meleddu
Rita Meleddu
VCValeria Cannas
Valeria Cannas
SDSimona Distinto
Simona Distinto
GSGiorgia Sarais
Giorgia Sarais
CVClaudia Del Vecchio
Claudia Del Vecchio
Enzo TramontanoEnzo Tramontano
Enzo Tramontano